LSTA
Lisata Therapeutics Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$45.16M
P/E Ratio
—
EPS
$-1.91
Beta
1.11
52W High
$5.07
52W Low
$1.81
50-Day MA
$4.68
200-Day MA
$2.95
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
2.71
PEG Ratio
118.40
About Lisata Therapeutics Inc.
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing cellular therapies to reverse disease and/or promote regeneration of damaged tissue. The company is headquartered in Basking Ridge, New Jersey.
Fundamentals
| Revenue (TTM) | 170,000 |
| Gross Profit (TTM) | 170,000 |
| EBITDA | $-18.06M |
| Operating Margin | -3079.00% |
| Return on Equity | -75.50% |
| Return on Assets | -43.10% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $1.68 |
| Price-to-Book | 3.05 |
| Price-to-Sales (TTM) | 265.66 |
| EV/Revenue | 137.76 |
| EV/EBITDA | 0.82 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -90.00% |
| Shares Outstanding | $9.03M |
| Float | $7.28M |
| % Insiders | 19.21% |
| % Institutions | 7.86% |
Analyst Ratings
Consensus ($9.50 target)
1
Strong Buy1
Buy1
HoldData last updated: 4/8/2026